ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,505Medicare Part D Prescriptions Filled, Including Refills

Rank: 383 out of 3734

$721K Total Retail Price of All Prescriptions

Rank: 294 out of 3734

318 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 6,137 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LISINOPRIL 416 222 1 3
METFORMIN HCL 347 212 2 8
SIMVASTATIN 332 254 3 1
OMEPRAZOLE 313 164 4 4
LEVOTHYROXINE SODIUM 299 203 5 2
TRAMADOL HCL 268 147 6 20
FUROSEMIDE 249 159 7 7
AMLODIPINE BESYLATE 245 204 8 5
METOPROLOL SUCCINATE 245 146 8 14
OXYCODONE-ACETAMINOPHEN 229 99 S2 10 51
METOPROLOL TARTRATE 210 109 11 6
PRAVASTATIN SODIUM 191 117 12 15
ZOLPIDEM TARTRATE 186 65 13 24
HYDROCHLOROTHIAZIDE 172 110 14 9
CRESTOR 165 85 15 28
HYDROCODONE-ACETAMINOPHEN 151 58 S3 16 12
SERTRALINE HCL 149 70 17 18
CYMBALTA 126 54 18 67
RANITIDINE HCL 119 50 19 32
SINGULAIR 115 46 20 95
CARVEDILOL 113 82 21 30
WARFARIN SODIUM 107 85 22 10
GLIMEPIRIDE 102 53 23 37
GABAPENTIN 101 36 24 17
SPIRIVA 98 49 25 40
CLOPIDOGREL 98 41 25 23
NEXIUM 96 45 27 36
MELOXICAM 95 26 28 52
ATORVASTATIN CALCIUM 95 66 28 11
AZITHROMYCIN 90 36 30 38
OXYCODONE HCL-ACETAMINOPHEN 89 44 S2 31 122
DEXILANT 87 25 32 243
LEVOFLOXACIN 85 35 33 116
ADVAIR DISKUS 82 44 34 35
QUETIAPINE FUMARATE 81 0 35 82
TIZANIDINE HCL 81 0 35 245
FLUTICASONE PROPIONATE 79 47 37 46
PROAIR HFA 78 30 38 83
CELEBREX 77 61 39 69
TAMSULOSIN HCL 77 57 39 29
MONTELUKAST SODIUM 73 21 41 175
ATENOLOL 71 62 42 13
MORPHINE SULFATE ER 69 14 S2 43 104
TRAZODONE HCL 69 26 43 49
ISOSORBIDE MONONITRATE ER 66 40 45 34
LYRICA 65 21 46 124
TRIAMTERENE-HCTZ 62 38 47 73
VENLAFAXINE HCL ER 61 12 48 84
NATEGLINIDE 61 48 48 276
TOPIRAMATE 60 0 50 181
PREDNISONE 60 36 50 42
CITALOPRAM HBR 59 35 52 16
TRIAMCINOLONE ACETONIDE 56 24 53 131
JANUVIA 56 39 53 50
CYCLOBENZAPRINE HCL 55 0 R 55 87
DIGOXIN 54 42 56 43
PLAVIX 54 26 56 39
DIOVAN 53 36 58 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 31 58 27
NIASPAN 52 24 60 125
NAPROXEN 51 25 61 101
ALLOPURINOL 50 30 62 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.